1. Home
  2. RAPT vs XBP Comparison

RAPT vs XBP Comparison

Compare RAPT & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • XBP
  • Stock Information
  • Founded
  • RAPT 2015
  • XBP N/A
  • Country
  • RAPT United States
  • XBP United Kingdom
  • Employees
  • RAPT N/A
  • XBP N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • XBP Business Services
  • Sector
  • RAPT Health Care
  • XBP Consumer Discretionary
  • Exchange
  • RAPT Nasdaq
  • XBP Nasdaq
  • Market Cap
  • RAPT 30.8M
  • XBP 36.2M
  • IPO Year
  • RAPT 2019
  • XBP N/A
  • Fundamental
  • Price
  • RAPT $0.89
  • XBP $1.01
  • Analyst Decision
  • RAPT Hold
  • XBP
  • Analyst Count
  • RAPT 10
  • XBP 0
  • Target Price
  • RAPT $5.00
  • XBP N/A
  • AVG Volume (30 Days)
  • RAPT 386.3K
  • XBP 31.7K
  • Earning Date
  • RAPT 11-12-2024
  • XBP 11-12-2024
  • Dividend Yield
  • RAPT N/A
  • XBP N/A
  • EPS Growth
  • RAPT N/A
  • XBP N/A
  • EPS
  • RAPT N/A
  • XBP N/A
  • Revenue
  • RAPT N/A
  • XBP $157,146,000.00
  • Revenue This Year
  • RAPT N/A
  • XBP N/A
  • Revenue Next Year
  • RAPT N/A
  • XBP N/A
  • P/E Ratio
  • RAPT N/A
  • XBP N/A
  • Revenue Growth
  • RAPT N/A
  • XBP N/A
  • 52 Week Low
  • RAPT $0.81
  • XBP $0.84
  • 52 Week High
  • RAPT $27.35
  • XBP $6.58
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 36.23
  • XBP 40.18
  • Support Level
  • RAPT $0.84
  • XBP $1.03
  • Resistance Level
  • RAPT $1.18
  • XBP $1.16
  • Average True Range (ATR)
  • RAPT 0.10
  • XBP 0.10
  • MACD
  • RAPT 0.01
  • XBP -0.02
  • Stochastic Oscillator
  • RAPT 17.00
  • XBP 3.41

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

Share on Social Networks: